GLOBE LIFE INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Credit Facility in Note
Credit Facility: On September 30, 2021, Globe Life amended the credit agreement dated August 24, 2020, which provides for a $750 million revolving credit facility that may be increased to $1 billion upon approval of the participating banks. The amended credit facility matures September 30, 2026, and may be extended up totwo one-year periods upon the Company's request. Pursuant to this agreement, the participating lenders have agreed to make revolving loans to Globe Life and to issue secured or unsecured letters of credit. The Company has not drawn on any of the credit to date. The facility is further designated as a back-up credit line for a commercial paper program under which the Company may either borrow from the credit line or issue commercial paper at any time, with total commercial paper outstanding not to exceed the facility maximum of $750 million, less any letters of credit issued. Interest is charged at variable rates. In accordance with the agreement, Globe Life is subject to certain covenants regarding capitalization. As of December 31, 2023, the Company was in full compliance with these covenants.
Commercial paper outstanding and any long-term debt due within one year are reported as short-term debt on the Consolidated Balance Sheets. A table presenting selected information concerning Globe Life's commercial paper borrowings is presented below.
Credit Facility—Commercial Paper
| At December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Balance commercial paper at end of period (at par value) | $319,000 | $285,000 |
| Annualized interest rate | 5.71% | 4.78% |
| Letters of credit outstanding | $115,000 | $125,000 |
| Remaining amount available under credit line | 316,000 | 340,000 |
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Average balance of commercial paper outstanding during period (par value) | $290,024 | $322,531 | $311,049 |
| Daily-weighted average interest rate (annualized) | 5.40% | 1.89% | 0.23% |
| Maximum daily amount outstanding during period (par value) | $477,700 | $500,529 | $465,033 |
| Commercial paper issued during period (par value) | 2,029,000 | 2,269,444 | 1,964,313 |
| Commercial paper matured during period (par value) | (1,995,000) | (2,314,477) | (1,889,280) |
| Net commercial paper issued (matured) during period (par value) | 34,000 | (45,033) | 75,033 |
The Company increased the commercial paper borrowings by $34 million from the prior year. We had no difficulties in accessing the commercial paper market under this facility during the year ended December 31, 2023 and 2022.
Federal Home Loan Bank (FHLB): FHLB membership provides our insurance subsidiaries with access to various low-cost collateralized borrowings and funding agreements. The membership requires ownership of FHLB common stock, as well as the purchase of activity-based common stock equal to approximately 4.1% of outstanding borrowings.
Globe Life owned $22.3 million in FHLB common stock as of December 31, 2023 and $14.3 million as of December 31, 2022. The FHLB stock is restricted for the duration of the membership and recorded at cost (par) as required by applicable guidance. The FHLB stock is included in "Other long-term investments" in the Consolidated Balance Sheets. Borrowings with the FHLB are subject to the availability of pledged assets at Globe Life. As of December 31, 2023, Globe Life's maximum borrowing capacity under the FHLB facility was approximately $1.0 billion, net of outstanding funding agreements and short-term borrowings, on pledged assets with a fair value of $1.3 billion. As of December 31, 2023, $138 million in funding agreements were outstanding with the FHLB, compared to $23 million as of December 31, 2022. This amount is included in "Other policyholders' funds" in the Consolidated Balance Sheets.
Note 13—Shareholders' Equity
Share Data: A summary of common share activity is presented in the following chart.
| Common Stock | ||
|---|---|---|
| Issued | TreasuryStock | |
| 2021: | ||
| Balance at January 1, 2021 | 113,218,183 | (9,420,699) |
| Grants of restricted stock | — | 10,031 |
| Vesting of performance shares | — | 210,155 |
| Issuance of common stock due to exercise of stock options | — | 1,191,704 |
| Treasury stock acquired | — | (5,642,036) |
| Retirement of treasury stock | (4,000,000) | 4,000,000 |
| Balance at December 31, 2021 | 109,218,183 | (9,650,845) |
| 2022: | ||
| Grants of restricted stock | — | 10,746 |
| Vesting of performance shares | — | 66,751 |
| Issuance of common stock due to exercise of stock options | — | 1,519,728 |
| Treasury stock acquired | — | (4,424,668) |
| Retirement of treasury stock | (4,000,000) | 4,000,000 |
| Balance at December 31, 2022 | 105,218,183 | (8,478,288) |
| 2023: | ||
| Grants of restricted stock | — | 7,110 |
| Vesting of performance shares | — | 84,298 |
| Issuance of common stock due to exercise of stock options | — | 1,375,313 |
| Treasury stock acquired | — | (4,415,287) |
| Retirement of treasury stock | (3,000,000) | 3,000,000 |
| Balance at December 31, 2023 | 102,218,183 | (8,426,854) |
There was no activity related to the preferred stock in years 2021 through 2023.
Acquisition of Common Shares: Globe Life shares are acquired through open market purchases under the Globe Life stock repurchase program when it is determined to be the best use of Globe Life's excess cash flows. This yields a return that is better than available alternatives and exceeds our cost of equity. When stock options are exercised, proceeds from the exercises are generally used to repurchase approximately the number of shares available with those funds in order to reduce dilution. See the following summary below:
| Globe Life Share Repurchase Program · Share Repurchase for Dilution Purposes | ||||||
|---|---|---|---|---|---|---|
| Shares Acquired (in thousands) · Total Cost · Average Price · Shares Acquired (in thousands) · Total Cost · Average Price | ||||||
| 2023 | 3,369 | $380,103 | $112.84 | 1,080 | $127,155 | $117.72 |
| 2022 | 3,322 | 335,145 | 100.90 | 1,103 | 119,493 | 108.33 |
| 2021 | 4,784 | 455,030 | 95.11 | 858 | 86,405 | 100.75 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.